Topics

FDA OKs Palforzia, First Drug for Peanut Allergy in Children

15:41 EST 31 Jan 2020 | Medscape

Palforzia will carry a boxed warning on the risk of anaphylaxis, and initial doses can be given only by certified professionals in certified settings.
FDA Approvals

Original Article: FDA OKs Palforzia, First Drug for Peanut Allergy in Children

NEXT ARTICLE

More From BioPortfolio on "FDA OKs Palforzia, First Drug for Peanut Allergy in Children"

Quick Search

Relevant Topics

Allergies
The term allergy is used to describe a response, within the body, to a substance, which is not necessarily harmful in itself, but results in an immune response and a reaction that causes symptoms and disease in a predisposed person, which in turn can cau...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...